Tavneos
Amgen splashes out on ChemoCentryx and its blockbuster hopeful
Phil Taylor
Amgen, ChemoCentryx, Immunology and inflammation, M&A, nephrology, Tavneos
0 Comment
X
Amgen splashes out on ChemoCentryx and its blockbuster hopeful
https://pharmaphorum.com/news/amgen-splashes-out-on-chemocentryx-and-its-blockbuster-hopeful/
Flash FDA approval sends ChemoCentryx spiralling upwards
Phil Taylor
autoimmune disease, avacopan, ChemoCentryx, fda, rare disease, regulatory approval, Tavneos
0 Comment
X
Flash FDA approval sends ChemoCentryx spiralling upwards
https://pharmaphorum.com/news/flash-fda-approval-sends-chemocentryx-spiralling-upwards/